BUTISOL SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Butisol Sodium patents expire, and when can generic versions of Butisol Sodium launch?
Butisol Sodium is a drug marketed by Meda Pharms and Pharmobedient and is included in two NDAs.
The generic ingredient in BUTISOL SODIUM is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUTISOL SODIUM?
- What are the global sales for BUTISOL SODIUM?
- What is Average Wholesale Price for BUTISOL SODIUM?
Summary for BUTISOL SODIUM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 10 |
| DailyMed Link: | BUTISOL SODIUM at DailyMed |
US Patents and Regulatory Information for BUTISOL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meda Pharms | BUTISOL SODIUM | butabarbital sodium | ELIXIR;ORAL | 085380-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | BUTISOL SODIUM | butabarbital sodium | TABLET;ORAL | 000793-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
